The seroprevalence of HCV in patients submitted to hemodialysis and health professionals in State of Minas Gerais, southest Of Brazil;Seroprevalencia del virus de la hepatitis C en pacientes en hemodiálisis y en profesionales de la salud en el Estado de Minas Gerais, región Sudeste de Brasil

Nefrologia

Volumn 28, Issue 2, 2008, Pages 178-185

  Oliveira Penido, J M M ^a,b   Caiaffa, W T ^c   Guimaraes Penido M ^d   Caetano, E V C ^c   Carvalho, A R ^c   Leite, A F ^c   Faria, S C ^c   Gomide, I V ^c   Rosa, A A B ^c   Penido, M G Maria Goretti ^c,d   Teixeira, R ^c  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b Núcleo de Nefrología de Belo Horizonte ^*

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Servicio de Nefrología de la Santa Casa de Belo Horizonte   (Brazil)

Author keywords

Chronic renal failure; Hemodialysis; Hepatitis C; Prevalence hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAZIL; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS C; HUMAN; INFANT; MALE; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES;

EID: 51149090390     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Centers for Disease Control and Prevention. Recommendations for preventing transmissions of infections among chronic hemodialysis patients. MMWR Morb Mortal Wkly Rept: Recommendations and Reports, Atlanta, v. 50, n.RR-5, pp. 1-43, Apr. 2001. disponível em: 〈http:/www.cdc.gov/mmwr/ PDF/rr/rr5050.pdf〉
2. World Health Organization. Global surveillance and control of hepatitis C. J Viral Hepatitis 1999; 6: 35-47.
3. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20 (1): 1-16.
4. Terrez-Speziale AM. Hepatitis C: historia natural y estado actual de su manejo. Rev Med Patol Clin 2003; 50: 179-189.
5. Wong JB, Mcquillan GM, Mchutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90 (10): 1562-1569.
6. Saab S, Brezina M, Gitnick G, Martin P, Yee HF Jr. Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 2001; 38: 91-97.
7. Tokars JI, Frank M, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002; 15 (3): 162-171.
8. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkondi S, Goubau P. HCV Collaborative Group. The changing epidemiology of hepatitis C virus infection in hemodialysis: European multicentre study. Nefhrol Dial Transplant 2004; 19 (4): 904-909.
9. García-Valdecasas J, Bernal C, García F, Leyva A, Cerezo S. Epidemiological factors involved in hepatitis C virus infection in patients with renal disease. Nephrol Dial Transplant 1995; 10 (6): 81-82.
10. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36 (1): 3-10.
11. Busek SU, Baba EH, Tavares Filho HA, Pimenta L, Salomão A, Correa-Oliveira R, Oliveira GC. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2002; 97 (6): 775-778.
12. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005; 45 (4): 684-689.
13. Natov SN, Lau JY, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS, Pereira BJ. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 1998; 31 (6): 920-927.
14. Furusyo N, Hayashi J, Kakuda K, Ariyama I, Kanamoto-Tanaka Y, Shimizu C, Etoh Y. Acute hepatitis among japanese hemodialysis patients: a prospective study 9 year study. Am Gastroenterol 2001; 96: 1593-1600.
15. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42 (4): 631-657.
16. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J 1998; 44 (1): 98-107.
17. Fabrizi F, Bunnapradist S, Lun J, Nefhrol GHI, Martin P. Kinetics of hepatitis C virus during hemodialysis: novel perspectives. J Nephrol 2003; 16 (4): 467-475.
18. Focaccia R, Da Conceição OJ, Sette HJR, Sabino E, Bassit L, Nitrini DR, Lomar AV, Lorenzo R, Vieira De Souza F, Kiffer CR, Santos EB, Gonzales MP, Sáez-Alquezar A, Riscal JR, Fischer D. Estimated Prevalence of Viral Hepatitis in the General Population of the Municipality of São Paulo, Measured by a Serologic Survey of a Stratified, Randomized and Residence-Based Population. Braz J Infect Dis 1998; 2 (6): 269-284.
19. Ferrari JO, Ferreira MU, Tanaka A, Mizokami M. The seroprevalence of hepatitis B and C in an Amerindian population in the southwestern Brazilian Amazon. Rev Soc Bras Med Trop 1999; 32 (3): 299-302.
20. Atlas do Desenvolvimento Humano do Brasil [Homepage na Internet] Brasília: Instituto Brasileiro de Geografia e Estatística - IBGE; c 1991-2000 [atualizada em 2000; acesso em 22/04/07] Disponível em: http://www.fjp.gov.br/produtos/cees/idh/atlas_idh.php.
21. Bergmaschi DP, Souza JMP, Braga PE. Introdução à Bioestatística. São Paulo, 2005. [Material de apoio Didático de Curso de Atualização do Programa de Verão da Faculdade de Saúde Pública da Universidade de São Paulo]. Disponível em: http://www.fsp.usp.br/~denisepb/bioverao 2005 apostila.pdf. Acesso em 23/08/07.
22. Resolução 196 do Conselho Nacional de Saúde, 1996. Homepage na Internet. Brasília [Acesso em 18/08/2007] Ministério da Saúde do Brasil, Disponível em: http://http://www.conselho. saude.gov.br/ .
23. Lombardi M, Cerrai T, Geatti S, Negroni S, Pertusini L, Pegoraro M, Di Lullo G. Results of a national epidemiological investigation of HCV infection in dialysis patients (Survey by the Italian Branch of EDTNA/ERCA) J Nephro 1999; 12: 322-327.
24. Cheney CP, Chopra S, Graham C. Hepatitis C. Infect Dis Clin North Am 2000; 14 (3): 633-667.
25. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345 (1): 41-52.
26. Giacchino F, Alloatti S, Quarello F, Bosticardo GM, Giraudo G, Piccoli G. The immunological state in chronic renal insufficiency. Int J Artif Organs 1982; 5 (4): 237-242.
27. Barros MT, Romão Junior JE. Resposta Imunológica na Uremia. En: Cruz, Jenner. Atualidades em Nefrologia. São Paulo: Sarvier, 1996. v 4, cap. 30, pp. 230-240.
28. Romão Junior JE, Pinto SWL, Canziani ME, Praxedes JN, Santello JL, Moreira JCM. Censo SBN 2002: informações epidemiológicas das unidades de diálise do Brasil. J Bras Nefrol 2003; 25 (4): 187-198.
29. Geerlings W, Tufveson G, Ehrich JH, Jones EH, Landais P, Loirat C, Mallick NP, Margreiter R, Raine AE, Salmela K. Report on management of renal failure in Europe XXIII. Neprhol Dial Transplant 1994; 9: S6-S25.
30. Penido JMMO, Soares NA, Salazar HM, Ferreira Filho S, Magela G. Estudo Epidemiológico dos pacientes renais crônicos em tratamento dialítico no Estado de Minas Gerais em 1994 e 1995. J Bras Nefrol 1996; 18 (3): 137-137.
31. US Renal Data System. USRDS 1999. Annual Date Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health. National Institutes of Diabetes and Digestive and Kidney Disease, Bethesda; 1999.
32. Sesso R. Inquérito epidemiológico em unidades de diálise do Brasil. J Bras Nefrol 2000; 22 (2): 23-26.
33. Dotta MA, Chequer H, Pereira JPM, Schimitt VM, Krug L, Saitovitch D. Métodos molecular e imunológico no diagnóstico da hepatite C em pacientes em hemodiálise. J Bras Nefrol 2003; 25: 86-94.
34. Oliveira MP. Diagnóstico da hepatite C em portadores de insuficiência renal crônica em hemodiálise: qual a melhor estratégia? Belo Horizonte: Faculdade de Medicina da Universidade Federal de Minas Gerais, 2005. 107 p. (Dissertação, Mestrado em Gastroenterologia).
35. El Nahas AM. & Bello AK. Chronic kidney Diseases: the global chalenge. Lancet 2005; 365: 331-340.
36. Sociedad Latnoamericana de Nefrologia e Hipertensión. Informe del año 2001. Incluye datos de los años 1991 a1999. Registro Latinoamericano de diálises e transplante renal. Disponível em: 〈http://www.slanh.org/registro. Acesso em 18/04/06.
37. Pinto dos Santos J, Loureiro A, Cendoroglo M, Pereira BJG. Impact of dialysis room and reuse strategies on the incidence of HCV infection in HD units. Nephrol Dial Transplant 1996; 11: 2017-2022.
38. Zatz R, Romão Junior JE, Noronha IL. Nephrology in Latin America, with special emphasis on Brazil. Kidney Int Suppl 2003; 83: S131-134.
39. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE. PHV Study Group. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2,796 patients. Gut 2002; 51 (3): 429-433.
40. Carneiro MA, Martins RM, Teles SA, Silva SA, Lopes CL, Cardoso DD, Vanderborght BO, Yoshida CF. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz 2001; 96 (6): 765-769.
41. Tokars JI, Miller ER, Alter MJ, Ardduino MJ. National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial 2000; 13 (2): 75-85.
42. Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004; 17 (4): 310-319.
43. Espinosa M, Martín-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, Aljama P. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004; 43 (4): 685-689.
44. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreno V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66 (4): 470-473.
45. Carithers RL Jr. Hepatitis C and renal failure. Am J Med 1999; 107 (6B): 90S-94S.
46. Oliveira GC, Carmo RA, Rocha MOC. Hepatitis C vírus genotypes in hemophiliacs in the state of Minas Gerais, Brasil. Transfusion 1999; 39: 1194-1199.
47. Busek S, Oliveira GC. Molecular epidemiology of the hepatitis C virus in Brasil. Gen Molec Res 2003; 2: 117-123.
48. Allander T, Medin C, Jacobson S, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43 (4): 415-419.
49. Fabrizi F, Martin P. Hepatitis C virus infection in dialysis: an emerging clinical reality. Int J Artif Organs 2001; 24 (3): 123-130.
50. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36 (1): 3-10.
51. Carneiro MA, Teles SA, Díaz MA, Ferreira RC, Naghettine AV, Silva SA, Lampe E, Yoshida CF, Martins RM. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz 2005; 100 (4): 345-349.
52. Brasil. Ministério da Saúde.Gabinete Do Ministro. Portaria no 2042 de 11 de outubro de 1996. Estabelece o Regulamento Técnico para O funcionamento dos Serviços De Terapia Renal Substitutiva e as normas para o cadastramento desses estabelecimentos junto ao Sistema Único de Saúde. Diário Oficial da União, Brasília, 14 de outubro de 1996.
53. Brasil. Programa das Nações Unidas para o Desenvolvimento (PNUD) Desenvolvimento humano e IDH, Disponível em: http://www.pnud.org. br/idh/. Acesso em 16/08/07.
54. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16 (5):1109-1114.
55. Germanaud J, Causse X, Dhumeaux D. Transmission of hepatitis C by accidental needlestick injuries. Evaluation of the risk. Presse Med 1994; 23 (23): 1078-1082.
56. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284 (4): 450-456.
57. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O. Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroentero 1994; 29 (4): 360-362.